Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...
It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2024, this June in Malta. The 7th World ...
The launch of Revvity, Inc. in May 2023 signaled the rebranding of an 85-year-old company with a dedicated focus on the diagnostics and life sciences sector. Bolstered through strategic acquisitions ...
The American Psychedelic Practitioners Association (APPA), a federal organization with the goal of safely integrating psychedelics into the U.S. healthcare system, has retained The Daschle Group as ...